TP53 and glioblastoma: To test whether the different response to MLN8237 was due to p53 status, we analysed levels of p53 expression in glioblastoma stem cell enriched and more differentiated populations in three primary cell lines: there was no common pattern of p53 levels in the various cell lines when comparing the two subpopulations (supplementary Fig. 4B–D).